Keimed - About the company
Keimed is a series B company based in Hyderabad (India), founded in 2000. It operates as a Pharmaceutical distributor of temperature-sensitive medicines. Keimed has raised $16.6M in funding from Apollo Hospitals and Mitsui, with a current valuation of ₹*****. The company has 1173 active competitors, including 2 funded and 19 that have exited. Its top competitors include companies like AmerisourceBergen, Entero Healthcare and Neelkanth Drugs.
Company Details
Pharmaceutical distributor of temperature-sensitive medicines. It sources products directly from manufacturers and maintains storage facilities, ensuring quality and effectiveness. The company utilizes a rapid logistics system for swift and precise delivery. Its advanced cold chain infrastructure and technology support seamless operations and maximize efficiency.
- Website
- keimed.com
- Registered Address
- 19 Bishop Gardens, R A Puram, Chennai, Ramakrishna Nagar (Chennai), Chennai, Chennai City Corporation, Tamil Nadu, India, 600028
Key Metrics
Founded Year
2000
Location
Hyderabad, India
Stage
Series B
Total Funding
$16.6M in 2 rounds
Latest Funding Round
Post Money Valuation
₹***** as on Mar 20, 2025
Investors
Ranked
3rd among 1173 active competitors
Annual Revenue
₹1,000+ Cr as on Mar 31, 2025
Employee Count
588 as on Mar 31, 2025
Similar Companies
Legal entities associated with Keimed
Keimed is associated with 3 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Keimed Private Limited CIN: U72200TN2000PTC179280 , India, Active | Mar 10, 2000 | ₹1,000+ Cr (As on Mar 31, 2025) | 384 (As on Apr 01, 2026) | |
Kamineni Enterprises International Llp CIN: ABC-9374 , India, Active | Nov 07, 2022 | ₹10 - ₹50 Cr (As on Mar 31, 2025) | - | |
AUSPHARMA PRIVATE LIMITED CIN: U24304TG2020PTC143079 , India, Active | Aug 22, 2020 | ₹500 - ₹1,000 Cr (As on Mar 31, 2025) | - |
Sign up to download Keimed's company profile
Keimed's funding and investors
Keimed has raised a total funding of $16.6M over 2 rounds. Its first funding round was on Aug 13, 2015. Its latest funding round was a Series B round on Mar 20, 2025 for $*****. 1 investor participated in its latest round. Keimed has 4 institutional investors.
Here is the list of recent funding rounds of Keimed:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Mar 20, 2025 | 7993143 | Series B | 7657685 | 3705533 | 6753349 | 8998963 |
Aug 13, 2015 | 7935845 | Series A | 4671636 | 1306615 | 7172210 |
Access funding benchmarks and valuations. Sign up today!View details of Keimed's funding rounds and investors
Keimed's founders and board of directors
Founder? Claim ProfileHere are the details of Keimed's key team members:
- Gaurav Chaturvedi: CEO of Keimed. Contact Info: 1 email address and 1 phone number
Keimed's Board of Directors
Keimed's board has 4 active members. Shobana Kamineni and Arvind Kumar Venkat are part of team and Puansh Kamineni and Raj Shankar are independent board members.Here is the list of Keimed's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Team | - | Current | 17y 11m | |
xggxruc | Team | - | Current | 6y 6m |
Independent board member | - | Current | 7y 8m | |
qfwnvqp | Independent board member | - | Current | 7y 8m |
View details of Keimed's Founder profiles and Board Members
Keimed's employee count trend
Keimed has 588 employees as of Mar 25. The total employee count is 68.0% more than what it was in Mar 24. Here is Keimed's employee count trend over the years:
Uncover Keimed's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Keimed's Competitors and alternates
Top competitors of Keimed include AmerisourceBergen, Entero Healthcare and Neelkanth Drugs. Here is the list of Top 10 competitors of Keimed, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | AmerisourceBergen 1985, Chesterbrook (United States), Public | Drug Corporation | - | 71/100 | |
2nd |  Entero Healthcare 2018, Mumbai (India), Public | Operator of an integrated healthcare products distribution platform | $59.7M | 66/100 | |
3rd | Pharmaceutical distributor of temperature-sensitive medicines | $16.6M | 59/100 | ||
4th |  Neelkanth Drugs 1989, Delhi (India), Unfunded | Distributor of pharmaceutical products | - | - | 47/100 |
5th |  Suresh Pharma Agencies 2009, Chennai (India), Unfunded | Distributor and supplier of pharmaceutical products to customers | - | - | 43/100 |
6th | Flagship Biotech 2008, Mumbai (India), Unfunded | Manufacturer of injectable, oral, and topical pharmaceutical formulations | - | - | 42/100 |
7th | Hospimax Healthcare 2009, Delhi (India), Unfunded | Distributor of pharmaceutical products | - | - | 41/100 |
8th |  Palepu Pharma 1989, Chennai (India), Unfunded | Distributor of pharmaceutical products | - | - | 41/100 |
9th | Trimurthi drugs and pharmaceuticals 1994, Hyderabad (India), Public | Traditional company engaged in pharmaceutical distribution and Retail pharmacy | - | - | 40/100 |
10th | Wonder Drugs 2015, Kolkata (India), Unfunded | Manufacturer and distributor of pharmaceutical goods, focusing on branded formulations. | - | - | 40/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Keimed's competitors? Click here to see the top ones
Keimed's Latest cap tables and shareholding
Founders own 12.73%, Funds own 0.00%, Parent Entities own 17.31% and Enterprises (largest shareholder) own 27.31%. The net worth of Keimed's founders is INR 825Cr as of Mar 20, 2025.
Shareholders Name | Post Round Holding % | Net worth | Cumulative Investment | Realised Returns | Unrealised Returns | Return Multiple |
|---|---|---|---|---|---|---|
Founder | 12.73% | 825Cr | 1800875 | 1784674 | 2743583 | 4221216 |
Fund | - | 0 | 0 | 0 | 0 | 0 |
0 | 0 | 0 | 0 | 0 | 0 | |
Parent Entity | 17.31% | 1,120Cr | 5154340 | 6538563 | 8432685 | 9162411 |
Enterprise | 27.31% | 1,770Cr | 2101403 | 9448062 | 3066211 | 2644940 |
Other People | 42.65% | 2,770Cr | 1328162 | 7460403 | 1266978 | 4922894 |
Total | 100.00% | 6,480Cr | 2435430 | 6126492 | 2826301 | 5702979 |
To unlock detailed Cap Table of Keimed Sign up today!Notes: The column Net Worth represents the net worth of investments made by that entity, as per the latest cap table.
DisclaimerView more details of Keimed's Shareholding
Keimed's Investments and acquisitions
Keimed has made no investments or acquisitions yet.
News related to Keimed
•
Apollo Healthco’s Investment Agreement with Advent and KeimedGlobal Legal Chronicle•Oct 15, 2024•Apollo Hospitals, Advent International, Keimed
•
Shardul Amarchand Mangaldas represents Apollo Hospitals Enterprise Limited, Apollo Healthco Limited and Keimed Private Limited before the Competition Commission of India in Advent International L.P.’s investment in Apollo Healthco, Apollo Healthco’s investment in Keimed and the merger of Keimed into Apollo Healthco - Shardul Amarchand Mangaldas & CoShardul Amarchand Mangaldas•Sep 02, 2024•Apollo Hospitals, Keimed, Advent International
•
•
•
Advent International to invest ₹2,475 cr. in Apollo HealthCoThe Hindu•Apr 26, 2024•Apollo Hospitals, Advent International, Apollo Health, Keimed and 6 others
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Keimed
Explore our recently published companies
- Servicevend - United Kingdom based, Unfunded company
- Alexandermagic - United Kingdom based, Unfunded company
- Bluehike - Unfunded company
- Ultran - Unfunded company
- Kayrospro - 2010 founded, Public company
- Chipconduit - Unfunded company
